Apotex is a Canadian-owned pharmaceutical company which researches, develops, manufactures and distributes 300 medicines to the healthcare system and exports these to 115 countries. Apotex's 2012 Research and Development (R&D) budget was $207 million - positioning it in the top 13 companies for all industrial sectors (20% of sales).
JACK KAY, CEO
150 Signet Drive
Toronto, ON M9L 1T9
Fax number: 416-401-3835
Apotex Inc. is not a subsidiary of any other parent companies.